Clinical studies have reported that approximately 20%-30% of COVID-19 patients have liver dysfunction, which is represented by elevated levels of alanine aminotransferase (ALT) or aspartate aminotransferase (AST)8,17,18. The gene discussed is GPT; the disease is COVID-19.